In the first ever Q4Bio Challenge, research teams sought to demonstrate scalable quantum algorithms for healthcare, with Algorithmiq's work alongside Cleveland Clinic and IBM earning $2 million Q4Bio ...
In his doctoral thesis, Michael Roop develops numerical methods that allow finding physically reliable approximate solutions ...
Christopher Leonard is director of marketing at Motivair by Schneider Electric When data center operators ask: what are the top AI cooling systems for AI workloads in data centers today? They are ...
Add Yahoo as a preferred source to see more of our stories on Google. Donald Trump speaks during the Republican National Convention on July 18, 2024. in Milwaukee, Wis. (Al Drago / Bloomberg via Getty ...
Former Premier League star Danny Murphy has highlighted two problems Chelsea need to fix if they are to make any progress. DOWNLOAD THE OFFICIAL CHELSEA NEWS APP FOR ALL THE LATEST UPDATES – STRAIGHT ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. It once seemed a bit up in the air if Netflix would actually renew 3 Body Problem, a series ...
A second Royal Commission of Inquiry into New Zealand’s experience and handling of the COVID pandemic released its substantial report today, running to several volumes and hundreds of pages. The ...
China could face ‘real problems’ within two months if Strait of Hormuz crisis drags on, expert warns
With Strait of Hormuz traffic nearly halted, China's reliance on Iranian oil could trigger "real problems" within two months if the crisis continues, one expert warned. Gatestone Institute senior ...
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will ...
Nektar Therapeutics is basking in the honeyed glow of long-term phase 2 data for its immune asset rezpegaldesleukin in atopic dermatitis, where the candidate successfully reduced the size and ...
AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...
Andy is a seasoned technology journalist with more than 15 years experience in the mobile industry, writing for Digital Trends, Wired, and more. During that time he has reviewed hundreds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results